首页 › 基金 › JOHNSON & JOHNSON › RAPP
JOHNSON & JOHNSON 对 RAPP 的持仓历史
RAPPORT THERAPEUTICS INC · 医疗保健
JOHNSON & JOHNSON 在 Q3 2026 的 13F 申报中披露持有 RAPP(RAPPORT THERAPEUTICS INC)1,784,517 股,市值约 US$60.0M,约占其申报组合的 7.87%,在其申报持仓中市值排名第 4 位。 JOHNSON & JOHNSON 最近 10 个申报季度中有 10 个季度披露了 RAPP 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
JOHNSON & JOHNSON 对 RAPP 的持仓演变
JOHNSON & JOHNSON 于 Q2 2024 首次披露 RAPP 持仓:2,498,051 股(约 US$58.1M)。 该持仓在 Q2 2026 达到峰值 1,784,517 股,市值约 US$74.4M。 在 10 次申报中,JOHNSON & JOHNSON 0 次增持、1 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 1,784,517 股、市值约 US$60.0M。 持仓曾出现大幅变动:Q3 2025 减持约 29% (随后一个季度股价上涨 2%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 2.50M | $58.10M | 新进 |
| Q3 2024 | 2.50M | $51.16M | 持有 |
| Q4 2024 | 2.50M | $44.32M | 持有 |
| Q1 2025 | 2.50M | $25.06M | 持有 |
| Q2 2025 | 2.50M | $28.55M | 持有 |
| Q3 2025 | 1.78M | $53.00M | 减持 |
| Q4 2025 | 1.78M | $54.14M | 持有 |
| Q1 2026 | 1.78M | $55.84M | 持有 |
| Q2 2026 | 1.78M | $74.36M | 持有 |
| Q3 2026 | 1.78M | $59.96M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RAPP 与 13F 数据
RAPP(RAPPORT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 RAPP,申报仓位最大的包括:TRV GP V, LLC (US$261.7M), ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RAPP 的基金
- TRV GP V, LLC 6.28M 股 · $261.71M · Q2 2026
- ARCH Venture Management, LLC 3.73M 股 · $155.38M · Q2 2026
- Cormorant Asset Management, LP 2.66M 股 · $110.74M · Q2 2026
- Sofinnova Investments, Inc. 1.90M 股 · $79.36M · Q2 2026
- BAKER BROS. ADVISORS LP 1.55M 股 · $64.47M · Q2 2026
- TRV GP VI, LLC 969.22K 股 · $40.39M · Q2 2026
- PERCEPTIVE ADVISORS LLC 773.34K 股 · $32.23M · Q2 2026
- Vestal Point Capital, LP 730.00K 股 · $30.42M · Q2 2026
- Siren, L.L.C. 641.47K 股 · $21.55M · Q3 2026
- Sio Capital Management, LLC 307.66K 股 · $12.82M · Q2 2026
- Burkehill Global Management, LP 250.00K 股 · $10.42M · Q2 2026
- Artia Global Partners LP 138.51K 股 · $5.77M · Q2 2026
更多关于 JOHNSON & JOHNSON
常见问题
How long has JOHNSON & JOHNSON held RAPP?
JOHNSON & JOHNSON has disclosed RAPP holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is JOHNSON & JOHNSON's current position in RAPP?
As of Q3 2026, JOHNSON & JOHNSON holds 1.78M shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $59.96M, representing 7.87% of its reported portfolio and ranking #4.
Has JOHNSON & JOHNSON been buying or selling RAPP?
In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in RAPP. The position peaked in Q2 2026 at 1.78M shares.
Which other funds hold RAPP?
Other major institutional holders of RAPP include TRV GP V, LLC, ARCH Venture Management, LLC, Cormorant Asset Management, LP, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.